We and others have extensively investigated and reported the underlying apoptotic mechanisms of IL-24 protein treatment and Ad.IL-24 infection in preclinical studies in several cancer cells including prostate cancer cells (DU-145), melanoma (HO-1), breast cancer cells (MCF-7), and cervical cancer cells (HeLa) (reviewed in [14,15]). Here, IL24 is linked to prostate cancer.